-
Symbol
-
CTSO on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.001 per share
-
Latest Disclosed Ownership
-
3.76M shares
-
Security Ownership
-
5.7%
Avenue Capital Management II, L.P. ownership in Cytosorbents Corp Common Stock, par value $0.001 per share (CTSO)
2025-05-28 - Avenue Capital Management II, L.P. has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 3.76M shares of Cytosorbents Corp Common Stock, par value $0.001 per share (CTSO).
This represents 5.7% percent ownership of the company.